|
|
|
|
Дата |
|---|
| 17.05.2026 |
| 14.05.2026 |
| 13.05.2026 |
| 12.05.2026 |
| 11.05.2026 |
| 10.05.2026 |
| 07.05.2026 |
| 06.05.2026 |
| 05.05.2026 |
| 04.05.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
76.52
|
74.10
|
79.90
|
75.03
|
|
|
7 775 011.65
|
423.00
|
|
|
|
78.00
|
76.00
|
78.00
|
76.52
|
|
|
4 366 375.79
|
318.00
|
|
|
|
76.22
|
76.20
|
79.99
|
78.00
|
|
|
19 862 198.41
|
481.00
|
|
|
|
74.50
|
73.61
|
79.00
|
76.22
|
|
|
34 926 750.85
|
742.00
|
|
|
|
74.51
|
72.50
|
75.90
|
74.50
|
|
|
5 397 619.53
|
353.00
|
|
|
|
71.98
|
72.06
|
76.87
|
74.51
|
|
|
23 002 504.44
|
876.00
|
|
|
|
70.73
|
70.78
|
72.79
|
71.98
|
|
|
4 005 570.33
|
332.00
|
|
|
|
70.73
|
70.78
|
72.79
|
71.98
|
|
|
4 005 570.33
|
332.00
|
|
|
|
70.06
|
69.00
|
73.40
|
70.73
|
|
|
15 623 069.61
|
640.00
|
|
|
|
69.40
|
68.01
|
71.95
|
70.06
|
|
|
11 930 227.72
|
559.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2022, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2014, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
08.01.2026
|
11.01.2026 |
1 EGP |
|
25.06.2023
|
03.07.2023 |
0.75 EGP |
|
02.01.2023
|
03.01.2023 |
3 EGP |
|
28.08.2020
|
31.08.2020 |
0.5 EGP |
|
01.12.2019
|
02.12.2019 |
0.5 EGP |
|
24.12.2017
|
25.12.2017 |
0.5 EGP |
|
11.11.2016
|
14.11.2016 |
0.5 EGP |
|
08.07.2015
|
09.07.2015 |
0.5 EGP |
|
24.05.2012
|
27.05.2012 |
0.75 EGP |
|
03.06.2011
|
06.06.2011 |
0.75 EGP |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products.
